Morten Leif Munding Stilund

  1. 2022
  2. Published
    Sammenlignende undersøgelse af højeffektiv, immunmodulerende medicin til attakvis multipel sklerose (CoSHED RMS). / Mærsk-Møller, Camilla Charlotte; Christensen, Tove; Vorup-Jensen, Thomas et al.
    2022. Abstract from Annual Meeting Danish MS Society.

    Research output: Contribution to conferenceConference abstract for conferenceResearch

  3. 2021
  4. Published
    Monocyte and Macrophage Markers in Multiple Sclerosis. / Stilund, Morten Leif Munding; Carstensen, Mikkel; Petersen, Thor et al.
    2021. Poster session presented at The 34th virtual conference of the European Macrophage and Dendritic cell Society (EMDS), Aarhus, Denmark.

    Research output: Contribution to conferencePosterResearchpeer-review

  5. 2020
  6. Published
    Activated monocytes and markers of inflammation in newly diagnosed multiple sclerosis. / Carstensen, Mikkel; Christensen, Tove; Stilund, Morten Leif Munding et al.
    In: Immunology and Cell Biology, Vol. 98, No. 7, 08.2020, p. 549-562.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  7. 2019
  8. Published
    Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis. / Bridel, Claire; van Wieringen, Wessel N; Zetterberg, Henrik et al.
    In: J A M A Neurology, Vol. 76, No. 9, 01.09.2019, p. 1035-1048.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  9. 2018
  10. Published
    Cerebrospinal fluid free kappa light chains and kappa index perform equal to oligoclonal bands in the diagnosis of multiple sclerosis. / Christiansen, Mikael; Gjelstrup, Mikkel Carstensen; Stilund, Morten Leif Munding et al.
    In: Clinical Chemistry and Laboratory Medicine, Vol. 57, No. 2, 2018.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  11. Published
    PRO-INFLAMMATORY MONOCYTE SUBSETS ARE AUGMENTED IN INCIPIENT AND PROGRESSED MULTIPLE SCLEROSIS. / Gjelstrup, Mikkel Carstensen; Stilund, Morten Leif Munding; Petersen, Thor et al.
    2018. Abstract from Aarhus University Graduate School of Health, PhD Day 2018.

    Research output: Contribution to conferenceConference abstract for conferenceResearch

  12. Published
    Subsets of activated monocytes and markers of inflammation in incipient and progressed multiple sclerosis. / Gjelstrup, Mikkel Carstensen; Stilund, Morten Leif Munding; Petersen, Thor et al.
    In: Immunology and Cell Biology, Vol. 96, 2018, p. 160-174.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  13. 2017
  14. Published
    Pro-inflammatory monocyte subsets are augmented in incipient and progressed Multiple Sclerosis. / Gjelstrup, Mikkel Carstensen; Stilund, Morten Leif Munding; Petersen, Thor et al.
    In: Multiple Sclerosis Journal, Vol. 23, No. S3, 2017, p. 1012.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperConference abstract in journalResearchpeer-review

  15. Published
    Pro-inflammatory monocyte subsets are augmented in incipient and progressed multiple sclerosis. / Gjelstrup, Mikkel Carstensen; Stilund, Morten Leif Munding; Petersen, Thor et al.
    2017. Poster session presented at 7th Joint ECTRIMS ACTRIMS Meeting , Paris, France.

    Research output: Contribution to conferencePosterResearchpeer-review

  16. 2016
  17. Published
    MONONUCLEAR CELLS IN MULTIPLE SCLEROSIS: AN ANALYSIS OF MONOCYTES AND B-CELLS AND THEIR ROLE IN DISEASE ACTIVITY. / Gjelstrup, Mikkel Carstensen; Stilund, Morten Leif; Møller, Holger Jon et al.
    2016. Poster session presented at Aarhus University Graduate School of Health, PhD Day 2016: set science free, Denmark.

    Research output: Contribution to conferencePosterResearch

  18. Published
    A multi-biomarker follow-up study of patients with multiple sclerosis. / Stilund, Morten Leif; Gjelstrup, Mikkel Carstensen; Christensen, Tove et al.
    In: Brain and Behavior, Vol. 6, No. 9, e00509, 2016.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  19. 2015
  20. Published
    Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel. / Stilund, Morten Leif; Gjelstrup, Mikkel Carstensen; Petersen, Thor et al.
    In: PLOS ONE, Vol. 10, No. 4, e0119681, 2015.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  21. 2014
  22. Published
    Biomarkers for treatment efficacy and prognosis in multiple sclerosis. / Stilund, Morten Leif; Christensen, Tove; Møller, Holger Jon et al.
    2014. Abstract from Aarhus University Graduate School of Health, PhD Day 2014, Aarhus, Denmark.

    Research output: Contribution to conferenceConference abstract for conferenceResearch

  23. Published
    Diagnostic contribution of soluble CD163 to a panel of biomarkers in newly diagnosed patients with multiple sclerosis. / Stilund, Morten Leif; Gjelstrup, Mikkel Carstensen; Petersen, Thor et al.
    In: Multiple Sclerosis, Vol. 20 SI, 2014, p. 179.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperConference abstract in journalResearchpeer-review

  24. Published
    Soluble CD163 as a Marker of Macrophage Activity in Newly Diagnosed Patients with Multiple Sclerosis. / Stilund, Morten Leif; Reuschlein, Ann-Kathrin; Christensen, Tove et al.
    In: P L o S One, Vol. 9, No. 6, 2014, p. e98588.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  25. 2013
  26. Published
    Soluble CD163 as a diagnostic marker in multiple sclerosis. / Stilund, Morten Leif; Møller, Holger Jon; Reuschlein, AK et al.
    2013. Poster session presented at Aarhus University Graduate School of Health, PhD Day 2013, Aarhus, Denmark.

    Research output: Contribution to conferencePosterResearchpeer-review

  27. Published
    Soluble CD163 in cerebrospinal fluid of patients with multiple sclerosis. / Stilund, Morten Leif; Møller, Holger Jon; Christensen, Tove et al.
    2013. Poster session presented at 29th ECTRIMS Congress, Copenhagen, Denmark.

    Research output: Contribution to conferencePosterResearchpeer-review

  28. Published
    Soluble CD163 in cerebrospinal fluid of patients with multiple sclerosis. / Stilund, Morten Leif; Møller, Holger Jon; Christensen, Tove et al.
    In: Multiple Sclerosis, Vol. 19 (SI), 2013, p. 298.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperConference abstract in journalResearchpeer-review

  29. 2012
  30. Published
    Soluble CD163 as a diagnostic marker in multiple sclerosis. / Stilund, Morten Leif; Møller, Holger Jon; Reuschlein, AK et al.
    2012. Poster session presented at PhD Day 2012, Aarhus, Denmark.

    Research output: Contribution to conferencePosterResearchpeer-review

  31. 2011
  32. Published
    Soluble CD163 as a diagnostic marker in multiple sclerosis. / Stilund, Morten Leif; Møller, Holger Jon; Reuschlein, A et al.
    In: Multiple Sclerosis, Vol. 17, No. S10, 2011, p. 499.

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperConference abstract in journalResearchpeer-review